Laboratory of Immunoendocrinology, School of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, SP, Brazil
Auto-generated profile, based on publicly available information
Luiz Adriano Damasceno Queiroz
Laboratory of Immunoendocrinology, School of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, SP, Brazil
Alloxan (ALX) and streptozotocin (STZ) are extensively used to induce type 1 diabetes (T1D) in animal models. This study is aimed at evaluating the differences in immune parameters caused by ALX and STZ. T1D was induced either with ALX or with STZ, and the animals were followed for up to 180 days. Both ALX and STZ induced a decrease in the total number of circulating leukocytes and lymphocytes, with an increase in granulocytes when compared to control mice (CT). STZ‐treated mice also exhibited an increase in neutrophils and a reduction in the lymphocyte percentage in the bone marrow. In addition, while the STZ‐treated group showed a decrease in total CD3+, CD4-CD8+, and CD4+CD8+ T lymphocytes in the thymus and CD19+ B lymphocytes in the pancreas and spleen, the ALX group showed an increase in CD4-CD8+ and CD19+ only in the thymus. Basal levels of splenic interleukin‐ (IL‐) 1β and pancreatic IL‐6 in the STZ group were decreased. Both diabetic groups showed atrophy of the thymic medulla and degeneration of pancreatic islets of Langerhans composed of inflammatory infiltration and hyperemia with vasodilation. ALX‐treated mice showed a decrease in reticuloendothelial cells, enhanced lymphocyte/thymocyte cell death, and increased number of Hassall’s corpuscles. Reduced in vitro activation of splenic lymphocytes was found in the STZ‐treated group. Furthermore, mice immunized with ovalbumin (OVA) showed a more intense antigen‐specific paw edema response in the STZ‐treated group, while production of anti‐OVA IgG1 antibodies was similar in both groups. Thereby, important changes in immune cell parameters in vivo and in vitro were found at an early stage of T1D in the STZ‐treated group, whereas alterations in the ALX‐treated group were mostly found in the chronic phase of T1D, including increased mortality rates. These findings suggest that the effects of ALX and STZ influenced, at different times, lymphoid organs and their cell populations.
Aging research increasingly relies on animal models to study the multifactorial processes of senescence. This study aimed to compare the physiological and metabolic parameters of C57BL/6J mice, a reference strain for biomedical research, with two strains commonly used to assess senescence: senescence‐accelerated resistant 1 (SAMR1) and senescence‐accelerated prone 8 (SAMP8) mice, over a 1‐year period, in order to enhance our understanding of their utility in aging research. We focused on reproductive performance, glucose metabolism, bone density, hematological profiles, and overall longevity. SAMR1 mice exhibited higher prolificacy compared to C57BL/6J and SAMP8, with no significant differences in other reproductive parameters. Both SAMR1 males and females were larger and heavier, while C57BL/6J mice consumed less food relative to their body weight. Bone density decreased in all male groups from the fourth to the tenth month, while SAMP8 females showed an unexpected increase. C57BL/6J mice presented higher glucose levels, with SAMP8 males showing similar glucose intolerance and insulin resistance. Hematological analyses revealed sexual dimorphism, with SAMP8 males showing a distinct immunosenescence profile. Longevity varied by strain and sex, with SAMP8 males and SAMR1 females exhibiting shorter lifespans. These findings suggest that SAMR1 animals, despite sharing a genetic background with SAMP8, display a phenotype more akin to normal aging, supporting their use as a control in aging studies. Moreover, SAMP8’s accelerated senescence makes it a valuable model for immunosenescence research. The study highlights the importance of considering strain‐ and sex‐specific differences when working on aging research.